Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Lana C. Pinto"'
Autor:
Lana C. Pinto, Dimitris V. Rados, Luciana R. Remonti, Marina V. Viana, Cristiane B. Leitão, Jorge L. Gross
Publikováno v:
Archives of Endocrinology and Metabolism, Vol 66, Iss 1, Pp 68-76 (2022)
ABSTRACT The lowest dosage of empagliflozin (10 mg) showed similar benefits on glycated hemoglobin (HbA1c) level, body weight, blood pressure, and total and cardiovascular mortality in comparison with the highest available dose (25 mg) in the EMPAREG
Externí odkaz:
https://doaj.org/article/9cbcb669a72e4f4984a41e7dca357787
Publikováno v:
Scientific Reports, Vol 8, Iss 1, Pp 1-6 (2018)
Abstract The use of dipeptidyl peptidase-4 (DPP-4) inhibitors may be associated with pancreatic cancer and acute pancreatitis. Recent meta-analyses have reported conflicting findings. Therefore, we performed a meta-analysis to assess the risk of both
Externí odkaz:
https://doaj.org/article/81b767a656f546529e3bc567694357bf
Autor:
Lana C. Pinto, Marcello C. Bertoluci
Publikováno v:
Archives of Endocrinology and Metabolism, Vol 64, Iss 3, Pp 199-200 (2020)
Externí odkaz:
https://doaj.org/article/38b6145659a24a9796bfad65d816d4fd
Autor:
Lana C. Pinto, Eliza D. Ricardo, Cristiane B. Leitão, Caroline K. Kramer, Claudete M. Zanatta, Jorge L. Gross, Luís H. Canani
Publikováno v:
Arquivos Brasileiros de Cardiologia, Vol 94, Iss 5, Pp 651-655 (2010)
FUNDAMENTO: Existem evidências indicando que o controle pressórico é mais efetivo na redução de complicações macrovasculares do diabete melito (DM) do que o controle glicêmico. No entanto, a redução da PA para os níveis recomendados pelas
Externí odkaz:
https://doaj.org/article/432a2aef646c4b25b5501dc0ee5d5548
Autor:
Jorge L, Gross, Caroline K, Kramer, Cristiane B, Leitão, Neil, Hawkins, Luciana V, Viana, Beatriz D, Schaan, Lana C, Pinto, Ticiana C, Rodrigues, Mirela J, Azevedo, Otávio, Berwanger
Publikováno v:
Annals of internal medicine. 154(10)
BACKGROUND: Few studies have examined the effect of adding a third antihyperglycemic drug when blood glucose control is not achieved by using metformin and a sulfonylurea. PURPOSE: To compare the efficacy of add-on antihyperglycemic drugs in patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::109855462608cdf342800b6e63f5c161
https://pubmed.ncbi.nlm.nih.gov/21576535
https://pubmed.ncbi.nlm.nih.gov/21576535
Autor:
Lana C, Pinto, Eliza D, Ricardo, Cristiane B, Leitão, Caroline K, Kramer, Claudete M, Zanatta, Jorge L, Gross, Luís H, Canani
Publikováno v:
Arquivos brasileiros de cardiologia. 94(5)
There is evidence indicating that blood pressure control is more effective in reducing macrovascular complications of diabetes mellitus (DM) than glycemic control. However, the reduction in BP to levels recommended by international guidelines is diff
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0fb99e6637c3c6353ad2f49a3db416fc
https://pubmed.ncbi.nlm.nih.gov/20428720
https://pubmed.ncbi.nlm.nih.gov/20428720